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Abstract: This study assessed the development of disseminated candidiasis within Galleria mellonella
larvae and characterized the proteomic responses of Candida albicans to larval hemolymph. Infection
of larvae with an inoculum of 1 × 106 yeast cells reduced larval viability 24 (53.33 ± 3.33%), 48
(33.33 ± 3.33%) and 72 (6.66 ± 3.33%) h post infection. C. albicans infection quickly disseminated
from the site of inoculation and the presence of yeast and hyphal forms were found in nodules
extracted from infected larvae at 6 and 24 h. A range of proteins secreted during infection of
G. mellonella by C. albicans were detected in larval hemolymph and these were enriched for biological
processes such as interaction with host and pathogenesis. The candicidal activity of hemolymph after
immediate incubation of yeast cells resulted in a decrease in yeast cell viability (0.23 ± 0.03 × 106 yeast
cells/mL), p < 0.05) as compared to control (0.99 ± 0.01 × 106 yeast cells/mL). C. albicans responded
to incubation in hemolymph ex vivo by the induction of an oxidative stress response, a decrease in
proteins associated with protein synthesis and an increase in glycolytic proteins. The results presented
here indicate that C. albicans can overcome the fungicidal activity of hemolymph by altering protein
synthesis and cellular respiration, and commence invasion and dissemination throughout the host.
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1. Introduction
Insects are now a widely used alternative to mammals for assessing the virulence of a range
of medically important microbial species such as Candida albicans [1,2], Aspergillus fumigatus [3–5],
Pseudomonas aeruginosa [6], or Campylobacter jejuni [7] and display many advantages over the use
of mammals [8]. Larvae of Galleria mellonella possess added advantages over other insect species
as they may be incubated at 37 ◦C, are easy to handle, possess a large volume of hemolymph with
a high density of immune cells which can be used in a range of ex vivo assays using techniques
already established with mammalian granulocytes [9]. Infection of larvae can be assessed by many
end points including survival, extent of melanization, variations in hemocyte density and microbial
load, histopathology, nodule formation and alterations in proteome [9–11].
The insect immune response shows many similarities to the mammalian innate defense
system [12]. Insect hemocytes display distinct anatomical and biochemical similarities to human
phagocytes. Pathways such as IMD and Toll have homologues in mammals and lead to the production
of a variety of antimicrobial peptides (AMPs) which play an essential role in curtailing microbial growth.
These include a range of anti-fungal peptides such as gallerimycin, a cationic inducible cysteine rich
defensin like peptide with antifungal activity, galliomicin a 43 amino acid AMP which is induced by
C. albicans [13–16]. Lepidopterans also produce moricins which are α-helical peptides which are highly
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active against yeasts and filamentous fungi [17]. Furthermore, glycine-rich gloverins AMPs were
significantly increased in abundance in response to infection by C. albicans and A. fumigatus [10,18].
Insect cecropins are a class of α-helical peptides which target the fungal membrane and induce
apoptosis of C. albicans and possess immunomodulatory effects on mammalian macrophages [19,20].
C. albicans is a dimorphic yeast capable of causing a wide range of systemic and disseminated
diseases in immunocompromised patients and is believed to cause 400,000 deaths per annum [21,22].
C. albicans possesses a variety of virulence attributes which it uses to detoxify and subvert the immune
response (e.g., secreted aspartyl proteinases), invade through tissue and disseminate throughout the
host [23]. G. mellonella larvae have been employed to study host fungal–pathogen interactions [18].
C. albicans infection in larvae results in alterations in immune cell function and type, changes in
hemolymph proteins (antimicrobial peptides, opsonin, proteins indicative of invasion) in an attempt to
control the increasing fungal burden which shows pathologies similar to disseminated renal candidiasis
in mice [18].
The aim of this study was to characterize the infection processes and dissemination of C. albicans
in G. mellonella larvae and to assess the responses of C. albicans as it interacts with the larval
immune response.
2. Materials and Methods
2.1. Larval Culture and Inoculation
Sixth instar larvae of the greater waxmoth G. mellonella (Livefoods Direct Ltd, Sheffield, England),
were stored in the dark at 15 ◦C to prevent pupation. Larvae weighing 0.22 ± 0.03 g were selected
and used within two weeks of receipt. Larvae were used according to standard procedures [18]. Ten
healthy larvae per treatment and controls (n = 3) were placed in sterile petri dishes lined with Whatman
filter paper and containing some wood shavings. Larvae were acclimatized to 30 ◦C for 1 h prior to all
experiments and incubated at 30 ◦C for all studies. All experiments were performed independently on
three separate occasions.
2.2. Yeast Strain
Candida albicans MEN (a kind gift from Dr. D. Kerridge, Cambridge, UK) was cultured in YEPD
broth (2% (w/v) glucose, 2% (w/v) bactopeptone (Difco Laboratories, Detroit, MI, USA), 1% (w/v)
yeast extract (Oxoid Ltd., Basingstoke, UK)) at 30 ◦C and 200 rpm in an orbital shaker overnight. Stocks
were maintained on YEPD agar plates (as above but supplemented with 2% (w/v) agar).
2.3. Effect of Candida albicans Infection on G. mellonella Larvae
Larvae were inoculated with C. albicans (1 × 104 to 1 × 107/20 µL PBS solution) through the last
left pro-leg and incubated at 30 ◦C. Survival of larvae was recorded at 24, 48, and 72 h.
2.4. Cryo-Imaging of C. albicans Infection in G. mellonella
G. mellonella were inoculated with 5 × 105 C. albicans cells for 0, 6, and 24 h at 30 ◦C. Larval
movement was inhibited by placement on ice. Larvae were embedded in Bioinvision Embedding
Compound and flash-frozen in liquid nitrogen and mounted on a stage for sectioning. Sectioning
and imaging was carried out every 10 µm using a CryovizTM (Bioinvision Inc., Cleveland, OH, USA)
cryo-imaging system.
2.5. Confocal Imaging of Fungal Nodules
G. mellonella larvae infected with C. albicans (5 × 105/20 µL) for 6 and 24 h at 30 ◦C were dissected in
PBS and nodules dissected apart with fine needles, transferred to a glass slide and stained with Calcofluor
white (Sigma, Gillingham, UK) for 30 min at 16 ◦C. The cells were washed twice with PBS and a cover
slide was placed on top. Cells were viewed with an Olympus Fluoview 1000 confocal microscope.
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2.6. Identification of C. albicans Proteins Secreted during Infection of G. mellonella Larvae
Ten larvae (n = 4) were infected with C. albicans (5 × 105/20 µL) for 24 h at 30 ◦C. Hemolymph
was collected, hemocytes removed by centrifugation 10,000× g for 10 min and hemolymph diluted in
PBS, quantified using Biorad Bradford protein quantification assay and acetone precipitated overnight
(75 µg). Proteins were subjected to label free quantitative LC-MS/MS.
2.7. Ex Vivo Hemolymph Fungicidal Activity Assay
Hemolymph (1 mL) was extracted from G. mellonella larvae, hemocytes were removed by
centrifugation (10,000× g for 10 min) and diluted with PBS. C. albicans cells (1 × 106/mL) were
suspended in 1 mL of each dilution of hemolymph (100, 50, 25%; maintained at 30 ◦C) and PBS
and aliquots taken at 0, 2, 4, 6, and 24 h and plated on YEPD agar plates supplemented with
erythromycin (0.1 mg/mL). Effect on yeast cell viability was determined by enumerating resulting
colonies after incubation.
2.8. Protein Isolation and Purification from C. albicans Exposed to Larval Hemolymph
C. albicans cells (2.5 × 107/mL) were incubated in PBS or G. mellonella hemolymph (100%; 1 mL)
for 6 h in Eppendorf tubes (n = 4) shaking at 200 rpm. Cells were centrifuged at 8000× g for 10 min,
washed 3 times with PBS and resuspended in lysis buffer (6 M urea, 2 M thiourea, 0.1 M Tris-HCl and
supplemented with protease inhibitor cocktail and pH adjusted to 8), subjected to sonication cycles
(30%, 10 s, 3 cycles) and clarified by centrifugation (10,000× g for 10 min). C. albicans whole cell protein
was acetone precipitated (75 µg) overnight by the addition of 3 times total volume of ice cold acetone.
Proteins were subjected to label free quantitative LC-MS/MS.
2.9. Label Free Quantitative Proteomics Workflow
Protein samples were analyzed by label free mass spectrometer by standard protein purification
procedures as described [10]. Peptide mix (1 µL of 0.75 µg/µL sample) was eluted onto a Q-Exactive
(ThermoFisher Scientific, Waltham, MA, USA) high resolution accurate mass spectrometer connected
to a Dionex Ultimate 3000 (RSLCnano) chromatography system. Peptides were separated by an
increasing acetonitrile gradient on a Biobasic C18 Picofrit™ column (ThermoFisher Scientific, Waltham,
MA, USA) using a 195 min reverse phase gradient at a flow rate of 250 nL /min. A high resolution MS
scan (300–2000 Dalton) was performed using the Orbitrap to select the 15 most intense ions prior to
MS/MS.
Protein identification from the MS/MS data was performed using the Andromeda search engine
in MaxQuant (version 1.2.2.5; http://maxquant.org/) to correlate the data against the proteome of
C. albicans (for response of C. albicans to hemolymph) obtained from uniport and the EST contigs of
G. mellonella obtained in house.
Results processing, statistical analyses and graphics generation were conducted using Perseus
v. 1.5.5.3 as described [10]. Proteins that had non-existent values (indicative of absence or very low
abundance in a sample) were also used in statistical analysis of the total differentially expressed group
following imputation of the zero values using a number close to the lowest value of the range of
proteins plus or minus the standard deviation. After data imputation these proteins were included in
subsequent statistical analysis. Identified proteins were grouped into functional categories based on
the GO (Gene Ontology) annotations, using the FungiFun application [24]. The Search Tool for the
Retrieval of INteracting Genes/Proteins (STRING) [25] v10.5 (http://string-db.org/) was used to map
known and predicted protein:protein interactions. UniProt gene lists (extracted from Perseus) were
inputted and analyzed in STRING using the medium confidence (0.5) setting to produce interactive
protein networks for proteins increased and decreased in abundance.
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2.10. Statistical Analysis
All experiments were performed on three independent occasions and results are expressed as
the mean ± S.E. analysis of changes in viability of C. albicans in larval hemolymph was performed
by One-way ANOVA. All statistical analysis listed performed using GraphPad Prism v6. Differences
were considered significant at p < 0.05.
2.11. Data Availability
The MS proteomics data and MaxQuant search output files have been deposited to the
ProteomeXchange Consortium [26] via the PRIDE partner repository with the dataset identifier
PXD011997 for response of C. albicans to hemolymph.
3. Results
3.1. The Effect of C. albicans Infection on G. mellonella Larvae
Infection of G. mellonella larvae with C. albicans at 1 × 104/20 µL and 1 × 105/20 µL did not
significantly alter larval viability 72 h post infection. However, an inoculum of 1 × 106/20 µL
significantly reduced larval viability at 24 (53.33 ± 3.33%), 48 (33.33 ± 3.33%) and 72 (6.66 ± 3.33%) h.
Infection of larvae with C. albicans cells at a density of 1 × 107/20 µL resulted in no larval survival 24 h
post infection (Figure 1).
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Figure 1. Ef ect of C. albicans cells on viability of G. mellonella larvae ov r 72 h. G. mellonel a larv e were
inoculated wi h 20 µL of C. albicans at doses ranging from 1 × 104 to × 107 incubated t 30 ◦C and
viability was assessed over 72 h. All values ar the mean ± SE of three independent experim nts.
Cryoviz cryo-i aging as used to visualize the dissemination of C. albicans (5 × 105/larva)
infection fro the point of inoculation throughout the larva (Figure 2). Nodules appeared around
the perimeter of the hemocoel 6 h post infection (see black arrows) indicating dissemination of the
C. albicans blastospores from the site of infection. By 24 h there as extensive elanization of larval
tissue and cuticle (white arrows) indicating invasion from the insect hemocoel into surrounding tissue,
and the formation of large fungal nodules (black arrows) at the site of inoculation and throughout
the larva (Figure 2). Visualization of melanized lesions dissected from infected larvae by confocal
microscopy at 6 and 24 h revealed the presence of hyphae (blue arrow) dispersed throughout nodules
(Figure 3). At 24 h hyphae (blue arrow) and yeast cells (orange arrow) are visible.
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3.2. Characterization of C. albicans Proteins Secreted during Infection of G. mellonella Larvae
Hemolymph from C. albicans infected larvae was isolated (t = 24 h) and MS performed. A total of
101 C. albicans proteins secreted or released during infection were detected in G. mellonella hemolymph.
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Seventeen uncharacterized proteins were detected during infection. Enrichment analysis using FunCat
GO terms, identified biological processes such as interaction with host (p = 1.4029 × 10−8), cellular
response to heat (p = 0.040686) and pathogenesis (p = 0.032202). Molecular functions such as protein
binding (p = 6.8596 × 10−7) and cellular components such as cytoplasm (p = 7.7444 × 10−7) and hyphal
cell wall (p = 7.6282 × 10−9) were all significantly enriched within this subset of proteins. Proteins
associated with the extracellular region (p = 6.8596 × 10−7) and cell surface (p = 1.7438 × 10−12) were
also enriched indicating these proteins are released or secreted during infection in larval hemolymph,
(Table S1).
Proteins that were implicated in pathogenesis were 14-3-3 protein homolog, cell wall protein 1,
potential fungal zinc cluster transcription factor, cell wall protein IFF5, cell surface mannoprotein
MP65, heat shock protein homolog SSE1, secreted protein RBT4, secreted beta-glucosidase SUN41, and
heat shock protein 90 homolog and enolase 1 (Table S2).
3.3. Assessment of Fungicidal Activity of Larval Hemolymph on Candida albicans (Ex Vivo)
In order to uncover the fate of C. albicans cells when first introduced into the larval hemolymph
the fungicidal activity of hemolymph was determined by incubation of yeast cells (106 cells/mL) in
different concentrations of hemolymph ex vivo over 24 h. There was a 76% decrease in the viability
of C. albicans after incubation in 100% hemolymph (0.23 ± 0.03 × 106, p < 0.05) as compared to PBS
(0.99 ± 0.01 × 106) after 0 h incubation. This effect was also observed after 4 (0.38 ± 0.03 × 106, p < 0.05)
and 6 (0.25 ± 0.04 × 106 p < 0.05) h incubation as compared to the control. However, incubation
of yeast cells in 50% and 25% hemolymph after 0 h resulted in no significant decrease in C. albicans
viability. Incubation of C. albicans in hemolymph (50% and 25%) for 2, 4 and 6 h resulted in a decrease
in yeast viability. After 24 h, the growth of C. albicans in whole hemolymph remained below the control,
however diluted hemolymph (50% (1.35 ± 0.23 × 106) and 25% (1.91 ± 0.08 × 106)) stimulated the
growth of C. albicans, (Figure 4).
J. Fungi 2019, 5 FOR PEER REVIEW  6 
 
3.2. Characterization of C. albicans Proteins Secreted During Infection of G. mellonella Larvae 
Hemolymph from C. albicans infected larvae was isolated (t = 24 h) and MS performed. A total 
of 101 C. albicans proteins secreted or released during infection were detected in G. mellonella 
hemolymph. Seventeen uncharacterized proteins were detected during infection. Enrichment 
analysis using FunCat GO terms, identifie  biological processes such as interaction with host (p = 
1.4029e-8), cellular response to heat (p = 0.040686) and pathogenesis (p = 0.032202). Molecular 
functions such as protein binding (p = 6.8596e-7) and cellular comp nents such as cytoplasm (p = 
7.7444e-7) and hyphal cell wall (p = 7.6282e-9) were all significantly enriched within this subset of 
proteins. Proteins associated with the extracellul r region (p = 6.8596e-7) and cell surface (p = 1.7438e-
12) were also enric ed indicating these proteins are released or secreted during infection in larval 
hemolymph, (Table S1). 
Proteins that were implicated in pathogenesis were 14-3-3 protein homolog, cell wall protein 1, 
potential fungal zinc cluster transcription factor, cell all protein IFF5, cell surface mannoprotein 
MP65, heat shock protein homolog SSE1, secreted protein RBT4, secreted beta-glucosidase SUN41, 
and heat shock protein 90 homol g and enolase 1(Table S2). 
3.3. Assessment of fungicidal activity of larval hemolymph on Candida albicans (ex vivo) 
In order to uncover the fate of C. albicans cells when first introduced into the larval hemolymph 
the fungicidal activity of hemolymph was determined by incubation of yeast cells (106 cells/mL) in 
different concentrations of hemolymph ex vivo over 24 h. There was a 76% decrease in the viability 
of C. albicans after incubation in 100% hemolymph (0.23 ± 0.03 × 106, p < 0.05) as compared to PBS (0.99 
± 0.01 × 106) after 0 h incubation. This effect was also observed after 4 (0.38 ± 0.03 × 106, p < 0.05) and 
6 (0.25 ± 0.04 × 106 p < 0.05) hour incubation as compared to the control. However, incubation of yeast 
cells in 50% and 25% hemolymph after 0 hour resulted in no significant decrease in C. albicans 
viability. Incubation of C. albicans in hemolymph (50% and 25%) for 2, 4 and 6 hour resulted in a 
decrease in yeast viability. After 24 h, the growth of C. albicans in whole hemolymph remained below 
the control, however diluted hemolymph (50% (1.35 ± 0.23 × 106) and 25% (1.91 ± 0.08 × 106)) 
stimulated the growth of C. albicans, (Figure 4). 
 
Figure 4. Candidacidal activity of G. mellonella larval hemolymph. C. albicans was incubated (30 °C) 
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Figure 4. Candidacidal activity of G. mellonella larval hemolymph. C. albicans was incubated (30 ◦C) in
varying concentrations (100%, 50%, 25%) of ex vivo hemocyte-free hemolymph or PBS and dilutions
were plated on YEPD agar plates to assess viability. Incubation of C. albicans in 100% hemolymph
decreased yeast cell viability by 76% at t = 0 incubation, by 64% at t = 4 h and 78% at t = 6 h. All values
are the mean ± S.E of three independent experiments, (*: p < 0.05).
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3.4. Proteomic Response of C. albicans to G. mellonella Hemolymph (Ex Vivo)
In order to understand how C. albicans responds to and survives the significant fungicidal activity
of hemolymph and ultimately disseminates throughout the host, label free quantitative proteomic
analysis was conducted on the proteome of C. albicans exposed to G. mellonella hemolymph (100%)
and PBS (control) for 6 h at 30 ◦C, (Figure 5). In total, 19,696 peptides were identified representing
1231 proteins with two or more peptides and 786 (hemolymph treated versus PBS treated C. albicans)
proteins were determined to be statistically significant differentially abundant (SSDA; ANOVA, p < 0.05)
with a fold change of >1.5 (260 increased and 526 decreased). A total of 361 proteins were deemed
exclusive (i.e., with LFQ intensities present in all three replicates of one treatment and absent in all
three replicates of the other treatment). These proteins were also used in statistical analysis of the
total differentially expressed group following imputation of the zero values as described. After data
imputation these proteins were included in subsequent statistical analysis. A principal component
analysis (PCA) performed on all filtered proteins distinguished the hemolymph and PBS treated
C. albicans samples indicating a clear difference between each proteome (Figure S1).
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Figure 5. Shotgun proteomics of responses of C. albicans (2.5 × 107/mL) to G. mellonella hemolymph
(100%) after 6 h incubated at 30 ◦C. Volcano plots showing the distribution of quantified proteins
according to p value (−log10 p-value) and fold change (log2 mean LFQ intensity difference). Proteins
above the horizontal line are considered statistically significant (p value < 0.05) and those to the right
and left of the vertical lines indicate relative fold changes ± 1.5. C. albicans responds to hemolymph by
altering the abundance of a range of proteins associated with a variety of biological process (enrichment
for; translation, glycolytic process, protein folding, oxidation-reduction process, and interaction with
host), molecular functions (structural constituent of ribosome, RNA binding, and metallopeptidase
activity) and cellular components (cytoplasm, ribosome and cell surface).
FungiFun analysis revealed enrichment for biological processes such as translation
(p = 6.6882 × 10−35), glycolytic process (p = 1.8762 × 10−7), protein folding (p = 1.1493 × 10−6),
oxidation-reduction process (p = 9.7092 × 10−6) and interaction with host (p = 0.00022661) in the
C. albicans incubated in hemolymph. Molecular functions such as structural constituent of ribosome
(p = 3.2372 × 10−19), RNA binding (p = 0.000003489) and metallopeptidase activity (p = 0.013756).
Cellular components of the cytoplasm (p = 2.7786 × 10−36), ribosome (p = 1.7021 × 10−19), and cell
surface (p = 1.5316 × 10−9) were also enriched within the SSDA proteins from C. albicans incubated in
hemolymph ex vivo (Table S3). These results were confirmed by STRING analysis (Figure 6).
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wise t-tests (p < 0.05). Each node represents a protein and each connecting line represents an interaction,
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The top 10 proteins increased in abundance in C. albicans incubated in hemolymph were D-arabinose
1-dehydrogenase (44 fold), karyopherin eta (12 fold), unchar cterized protei (11.5 fold), Arf family
GTPase (8 fold), 5-oxoprolinase (8 fold), karyopherin (8 fold), carboxymethylen butenolidase (8 f l ),
TP-dependent (S)-NAD(P)H-hydrate dehydratase (8 fold), 3-hydroxyanthranilat 3,4-dioxygenase
(8 fold) and Leu42p (7.5 fol ), (Table S4A). The top 10 proteins decreased in bundance in C. albicans
incubated in hemolymph were uncharacterized protein (374 fold), uncharacterized protein (259.5 fold),
ribosomal 60S subunit protein L16A (235 fold), ribosomal 60S subunit protein L25 (201.5 fold), pyruvate
dehydrogenase E1 component subunit alpha (187 fold), Bfr1p (184 fold), ribosomal 60S subunit protein
L34B (176 f ld), rRNA methyltransferase (155.5 f l ), glutamate ecarboxylase (152 f ld) a d ribosomal
40S subunit pr tein S11A (149 fold), (Table S4B).
4. Discussion
C. albicans is the most common nosocomial fungal pathogen of humans and causes a broad
spectrum of diseases depending on the immune status of the host with a mortality rate of 40% in
certain patie t groups [22]. C. albicans possesses an arsenal of virulence factors to establi h a f cal
poin of infection, adher to and invade host cells, detoxify the cellular immune response and degrade
omponents of the humoral immune respon e [27]. The C. albicans cell wall is als a complex mesh
of polysaccharides, proteins and sterols which help to orm a physical barri agai t the immun
response but also signals are relayed from the wall depending o th stimulus in order for the fungal
cel to adequately m unt an appropriate stress r s onse [28].
I this study, the infection processes and responses of C. albicans following exp sure to G. mello ella
h molymph were investig ted. Infection with C. albica s resulted in a dose dependent decrease in larval
viability over 72 h. An inoculum of 1 × 105 resulted in o change in v ability, while 1 × 106 yeast cells
reduces l rval viability to 6.66 ± 3.33% after 72 h, (Figure 1). The use of Cryo-imaging revealed infection
by C. lbicans commenced imm diately with extensive melanization arou d the area of inoculation at 6 h
(Figure 2). Th re were discrete nodules in the middle of the larvae and these consist d of viable fungal
hyphae. By 24 h larvae were heavily infected with disseminated C. albicans as observed by extensive
cuticular melanization and the appearance of large nodules throughout the host. A similar process has
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been documented in patients with chronic candidiasis where immune cells surround the pathogen and
initiate an inflammatory response to prevent dissemination [29]. Dissection of nodules at 6 and 24 h
revealed the presence of hyphae at 6 hour with the addition of yeast cells at 24 h (Figure 3).
Proteins released by C. albicans during infection of larvae were also analyzed. In total 101
C. albicans proteins were found in hemolymph during infection and biological processes such as
interaction with host (p = 1.4029 × 10−8), cellular response to heat (p = 0.040686) and pathogenesis
(p = 0.032202) were enriched. Interestingly, cell wall protein 1 is a heme-binding protein involved
in heme-iron utilization and required for biofilm formation and is preferentially expressed during
the mycelium growth phase, induced by iron starvation and ciclopirox [30–32]. Peroxiredoxin is a
thiol specific peroxidase that catalyses the reduction of hydrogen peroxide and also plays a role in cell
wall protection against oxidative stress [33]. Enolase 1 binds to plasminogen and results in enhanced
invasion of human brain microvascular endothelial cells [34]. Heat shock protein SSA1 binds to histatin
5, an important antimicrobial peptide against C. albicans oral infection [35]. Cell surface mannoprotein
MP65 which is a major antigen and induces T-cell proliferation, DC maturation and is required for
hyphal morphogenesis and surface adherence during infection [36,37]. Antigenic secreted protein
RBT4 acts as a virulence factor during infections and plays a role in protection against phagocyte
attack [38]. Moreover, a range of cell wall derived proteins were detected in hemolymph such as
chitin synthase, cell wall protein PGA59, cell wall protein IFF5 and secreted beta-glucosidase SUN41.
Proteins associated with translation (translation initiation factor eIF2B subunit delta, translation factor
GUF1, translation elongation factor 1 subunit beta) and the ribosome (60S ribosomal protein L27) were
detected in hemolymph and may have been released from C. albicans during cell death.
Exposure of yeast cells to larval hemolymph resulted in significant reductions in viability. At t = 0,
100% hemolymph reduced the viability of C. albicans by 76% (0.23 ± 0.03 × 106, p < 0.05) as compared to
the PBS control (0.99 ± 0.01 × 106), (Figure 4). This indicates that the candicidal activity of hemolymph
is highly active even in naïve larvae. C. albicans viability remained significantly lower than that of the
control at 4 and 6 h. G. mellonella hemolymph is rich in antimicrobial peptides and proteins such as
cecropins, moricins, gloverins, 6-tox, lysozyme, gallerimycin, and galliomicin. Many of these peptides
have fungicidal activity and C. albicans increases the abundance of cecropins during infection [18].
Furthermore, cecropin-A induced apoptosis of C. albicans by disrupting intracellular ion balance and
the glutathione antioxidant system [19]. A range of these AMPs are inducible thus indicating that naive
hemolymph has significant constitutively expressed antifungal molecules. Cecropins and moricins
are increased in abundance at 6 h post infection with C. albicans and A. fumigatus respectively in
G. mellonella larvae [10,18].
In order to characterize the molecular responses of C. albicans to hemolymph, protein was extracted
from the cells after 6 h exposure to hemolymph ex vivo and subjected to mass spectrometry. STRING
analysis of proteins decreased in abundance from C. albicans cells incubated in hemolymph revealed
enrichment for biological processes associated with the ribosome, translation, and ribonucleoprotein
complex. A decrease in these proteins indicates a decrease in global protein synthesis. Gene expression
associated with protein synthesis was decreased late during experimental bloodstream infection
in mice and this decrease in protein synthesis was associated with an increase in gene expression
associated with glycolysis, oxidative stress, fermentation, and genes associated with interaction with
the host which it may use to escape from the bloodstream [39]. Larval hemolymph induced increases
in the abundance of C. albicans proteins associated with the same processes. Incubation of C. albicans in
human serum and G. mellonella hemolymph activates similar processes in order for the fungal cell to
survive in the host. Furthermore, proteins associated with oxidative phosphorylation, the TCA cycle
and the mitochondria were all decreased in abundance probably resulting in an overall decrease in
cellular respiration [40]. C. albicans deficient in respiration were resistant to histatin 5 and disruption
of mitochondria also allows increased growth in the presence of amphotericin B [41]. Therefore a
decrease in mitochondrial respiration may allow the cell to withstand the hostile environment within
hemolymph during infection.
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Proteins associated with an oxidative stress response such as thioredoxin, thioredoxin reductase,
superoxide dismutase, glutathione-disulfide reductase, thioredoxin peroxidase were increased in
abundance in hemolymph-incubated cells. Heat shock proteins (hsp) such as hsp homolog SSE1, hsp
SSA1, hsp SSA2 and hsp SSC1 were also elevated in abundance. Hsp SSA1 and SSA2 induce host cell
endocytosis which lead to increased virulence [42] and also play a role in resistance to antimicrobial
peptides and antifungal agents [35,43,44]. Interestingly, hsp SSA1 and peroxiredoxin TSA1 were also
found secreted into G. mellonella hemolymph during infection in this study. Candidapepsin-9 is a
glycosylphosphatidylinositol-anchored protease and important virulence factor found to activate
human neutrophils more effectively than any other SAP [45] and was increased 1.8 fold in C. albicans
incubated in hemolymph in this study.
5. Conclusions
Upon infection, C. albicans disseminates through G. mellonella larvae in a similar way to mammals.
Exposure of C. albicans to hemolymph leads to the activation of processes associated with a decrease in
protein synthesis and an increase in the abundance of proteins associated with pathogenesis, glycolysis,
and responses to oxidative stress. Some of these proteins are secreted and detectable in hemolymph
during infection. The results presented here indicate that upon infection of G. mellonella larvae with
C. albicans there is the activation of similar processes in C. albicans by insect hemolymph as are activated
by human sera and uncovering these similarities will further extend the utility of this system for
studying pathogen-host interactions.
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